Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Jan;11(1):160-164.
doi: 10.1177/1932296816667749. Epub 2016 Sep 25.

Regulation Catches Up to Reality

Affiliations

Regulation Catches Up to Reality

Steven V Edelman. J Diabetes Sci Technol. 2017 Jan.

Abstract

The FDA recently conducted an Advisory Panel meeting to evaluate the safety, efficacy, and benefits of granting a nonadjunctive label claim for the DEXCOM G5 Mobile continuous glucose monitoring (CGM) system. If approved, this claim will allow users to make day-to-day treatment decisions, including insulin dosing directly from the glucose values and rate of changes arrows generated by the CGM device, without the requirement of a confirmatory measurement with a self-monitoring blood glucose (SMBG) meter. Sporadic SMBG testing gives limited data, while CGM gives a value every 5 minutes and has alerts, alarms, trending information and allows caregivers to follow the user in real time 24/7. This indication will lead to more wide spread use of CGM and improve overall care with protection of hypoglycemia.

Keywords: CGM; FDA panel meeting; SMBG; nonadjunctive claim.

PubMed Disclaimer

Conflict of interest statement

Declaration of Conflicting Interests: The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Figures

Figure 1.
Figure 1.
One suggestion for patients using CGM on how to adjust their meal and correction insulin does based on trend arrows. The concept is to use the anticipated glucose value in 30 minutes based on the ROC curves when calculating how much insulin to give at meal time and when correcting for incidental hyperglycemia.

References

    1. Food and Drug Administration. Advisory committees. Available at: http://www.fda.gov/AdvisoryCommittees/default.htm. Accessed August 12, 2016.
    1. Beck RW, Tamborlane WV, Bergenstal RM, et al. The T1D Exchange Clinic Registry. J Clin Endocrinol Metab. 2012;97:4383-4389. - PubMed
    1. Pettus J, Price DA, Hill KJ, Edelman S. How people use direction and rate of change information provided by real-time continuous glucose monitoring (RT-CGM) to adjust insulin dosing. Diabetes Technol Ther. 2014;16(S1):198. - PubMed
    1. Pettus JH, Hirsch IB, Edelman SV. Practical Management of Type 1 Diabetes. 2nd ed. Greenwich, CT: Professional Communications; 2013.
    1. Kovatchev BP, Breton MD, Dalla Man C, Cobelli C. In silico preclinical trials: a proof of concept in closed-loop control of type 1 diabetes. J Diabetes Sci Technol. 2009;3:44-55. - PMC - PubMed

MeSH terms